Detalles de la búsqueda
1.
Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.
Ann Oncol
; 29(7): 1535-1540, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722791
2.
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.
Ann Oncol
; 25(7): 1340-1346, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24608196
3.
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.
Ann Oncol
; 25(7): 1333-1339, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24631949
4.
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
Ann Oncol
; 27(suppl 5): v119-v133, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27664248
5.
A randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.
Curr Oncol
; 27(2): e156-e162, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32489264
6.
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
ESMO Open
; 9(2): 102195, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458657
7.
Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin.
J Natl Cancer Inst
; 81(1): 42-6, 1989 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-2521184
8.
Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
Cancer Res
; 41(6): 2417-20, 1981 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-6940656
9.
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
Cancer Res
; 43(12 Pt 1): 6096-101, 1983 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-6580068
10.
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
Cancer Res
; 41(4): 1402-6, 1981 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-6783296
11.
Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.
Cancer Res
; 48(19): 5573-9, 1988 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-3416310
12.
Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.
J Clin Oncol
; 6(4): 659-62, 1988 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-2965755
13.
Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin.
J Clin Oncol
; 6(4): 663-8, 1988 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-3282034
14.
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
J Clin Oncol
; 11(9): 1757-62, 1993 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-8394881
15.
Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.
J Clin Oncol
; 10(3): 484-98, 1992 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-1311028
16.
Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
J Clin Oncol
; 7(1): 108-14, 1989 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-2642536
17.
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin.
J Clin Oncol
; 12(10): 2204-10, 1994 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-7931490
18.
Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
J Clin Oncol
; 13(3): 637-44, 1995 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-7533824
19.
Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.
J Clin Oncol
; 6(3): 446-50, 1988 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-2832548
20.
Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
J Clin Oncol
; 17(1): 338-43, 1999 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10458252